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Membrane-active mechanismArenicin-1 is a 21-residue peptide which was derived from Arenicola marina. In this study, we investigated
the antifungal effects and its mechanism of action towards human pathogenic fungi. Arenicin-1 exerted
remarkable fungicidal activity with both energy-dependent and salt-insensitive manners. To investigate the
fungicidal mechanisms of arenicin-1, the membrane interactions of arenicin-1 were examined. Flow
cytometric analysis, using propidium iodide (PI) and bis-(1,3-dibutylbarbituric acid) trimethine oxonol
[DiBAC4(3)], as well as ﬂuorescence analysis, regarding the membrane probe 1,6-diphenyl-1,3,5-hexatriene
(DPH), were conducted against Candida albicans. The results demonstrated that arenicin-1 was associated
with lipid bilayers and induced membrane permeabilization. Additionally, the membrane studies in regard to
liposomes resembling the phospholipid bilayer of C. albicans conﬁrmed the membrane-disruptive potency of
arenicin-1. Therefore, the present study suggests that arenicin-1 exerts its fungicidal effect by disrupting
fungal phospholipid membranes.© 2009 Elsevier B.V. All rights reserved.1. IntroductionMarine invertebrates lack an acquired, memory-type immunity
based on T-lymphocyte subsets and clonally derived immunoglobu-
lins. This characteristic differs from that of the vertebrate immune
system, which is characterized by somatic gene rearrangement, clonal
selection, expansion, and a discriminative ability which includes
lymphocytes, among other factors, which impart speciﬁcity and
memory. The circulating hemolymph inmarine invertebrates contains
biologically active substances such as complement, lectins, clotting
factors, and antimicrobial peptides [1–3]. These factors contribute to a
self-defense system in marine invertebrates against invading micro-
organisms. Above all, antimicrobial peptides, such as tachyplesin from
acid extracts of large hemocyte granules of Tachypleus tridentatus,
clavanin from Styela clava and mytilin from Mytilis edulis, are major
components of the innate immune defense system in marine
invertebrates, and also provide an immediate and rapid response to
invading microorganisms [4–7].
Arenicin-1 (RWCVYAYVRVRGVLVRYRRCW), a 21-residue antibac-
terial peptide, is a β-sheet peptide isolated from the coelomocytes of
the marine polychaeta lugworm, Arenicola marina [8]. This peptide
has been reported to exhibit broad antibacterial activity against
human pathogenic bacterial strains [9]. The structure of arenicin-1
was found to consist of two stranded anti-parallel β-sheet, con-
strained by one disulﬁde bond and connected by a β-turn. As arenicin-
1 bears a net positive charge (+6) in combination with a substantial
number of hydrophobic amino acid residues, extensive research+82 53 955 5522.
ll rights reserved.regarding a membranolytic steps involved in the killing of bacterial
strains have been conducted [10]. However, the antifungal activity and
its mechanism are still far from being fully answered.
In this study, the antifungal activity of arenicin-1 was investigated,
and the mode of action was elucidated by exploring the virtual area
from the intact fungal cell membrane to the artiﬁcial phospholipid
membrane model.
2. Materials and methods
2.1. Peptide synthesis
The peptides were synthesized by the solid-phase method using
Fmoc(9-ﬂuorenyl-methoxycarbonyl)-chemistry [11]. The crude pep-
tide was repeatedly washed with diethylether, dried in a vacuum, and
puriﬁed using a reversed-phase preparative HPLC on a Waters 15-μm
Deltapak C18 column (19×30 cm). The purity of the peptide was
conﬁrmed by an analytical reversed-phase HPLC on an Ultrasphere C18
column, 4.6×25 cm (Beckman, U.S.A.). The molecular weights of the
synthetic peptides were determined using a matrix-assisted laser
desorption ionization MALDI-mass spectrometer [12].
2.2. Fungal strains and antifungal activity assay
Candida albicans (ATCC 90028) and Candida parapsilosis (ATCC
22019) were obtained from the American Type Culture Collection
(ATCC) (Manassas, VA). Candida albicans (TIMM 1768) was obtained
from the Center for Academic Societies, Osaka, Japan. Trichophyton
rubrum (KCTC 6345),Malassezia furfur (KCTC 7744), and Trichosporon
beigelii (KCTC 7707) were obtained from the Korean Collection for
Table 1
The antifungal activity of arenicin-1.
Fungal strains MIC (μM)
Arenicin-1 Melittin
C. albicans ATCC 90028 9 2.5
C. albicans TIMM 1768 9 2.5
C. parapsilosis ATCC 22019 4.5 2.5
M. furfur KCTC 7744 9 5
T. beigelii KCTC 7707 4.5 5
T. rubrum KCTC 6345 9 5
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Biotechnology (KRIBB), Daejeon, Korea.
The fungal strains were cultured in a YPD medium (Difco), con-
taining yeast extract, peptone, and dextrose (50 g/L), with aeration at
28 °C. M. furfur was cultured in a modiﬁed Bacto yeast extract/ malt
extract (YM) medium (Difco) containing yeast extract, malt extract,
peptone, dextrose (21 g/L), and 1% olive oil at 32 °C.
Log-phase fungal cells (2×104/ml) were inoculated into a YPD
medium and dispensed into 0.1 ml/well microtiter plates. MICs were
determined by a serial two-fold dilution of test peptides, following a
micro-dilution method and MTT (3-(4,5-dimethyl-2-thiazolyl)-2,5-
diphenyl-2H-tetrazolium bromide) assay [13,14]. After 48 h of
incubation at 28 °C, the minimal peptide concentration which
prevented the growth of a given test organism was determined, and
was deﬁned as the MIC. The growth was assayed with a microtiter
ELISA Reader (Molecular Devices Emax, California, U.S.A.) by monitor-
ing absorption at 580 nm. The MIC values were determined by three
independent assays.
2.3. Time-killing kinetics
The kinetics of fungal killing of the peptides were evaluated by
using C. albicans cells. Log-phase fungal cells (2×106/ml YPD) were
incubated with peptides at two times the MIC. The culture was
obtained and distributed on an YPD agar plate, then the colony
forming units (CFUs) were counted after 24 h incubation at 28 °C
[15,16]. The results represent the average of triplicate measurements
from three independent assays.
2.4. The effect of arenicin-1 on the dimorphic transition in C. albicans
C. albicans cells were maintained by periodic subculturing in a YPD
medium. To induce the formation of mycelia, the cultures were
directly supplemented with 20% fetal bovine serum (FBS). The
dimorphic transition in C. albicans was investigated from the cultures
in the presence or absence of arenicin-1, and incubated for 48 h at
37 °C [17]. The dimorphic transition tomycelial forms was detected by
phase-contrast light microscopy (NIKON, ECLIPSE TE300, Japan).
2.5. The effect of NaN3 on antifungal activity of arenicin-1
C. albicans cells (2×106/ml) were incubated for 1 h with 0.1 mM
NaN3 prior to treatment with the peptide, and then were incubated
for 24 h at 28 °C in a YPD medium. The cell population was illustrated
by MTT assay [14]. The absorbance of each well was measured at
580 nm by using a Microtiter ELISA Reader (Molecular Devices Emax).
The equation of the cell viability percentage is illustrated as follows:
[(the absorbance of the compound-treated cells)/(the absorbance of
non-treated cells)]×100. The error bars represent the standard
deviation (S.D.) values for three independent experiments, per-
formed in triplicate [18].
2.6. Membrane permeabilization assay and salt-sensitivity test of arenicin-1
For the analysis of the permeabilization of fungal membrane after
peptide treatment, C. albicans cells (2×106/ml) were ﬁrst harvested
at the log phase and suspended in a YPD medium. Cells were
incubated with peptides at two times the MIC for 2 h at 28 °C with
constant shaking (140 rpm). For the salt-sensitivity test, cells were
incubated with arenicin-1 at two times the MIC in the presence or
absence of various salt conditions (ﬁnal concentrations; 150 mM NaCl
and 3 mM MgCl2) After incubation, cells were harvested by
centrifugation and suspended in PBS. Subsequently, cells were treated
with PI (9 μM, ﬁnal concentration) for 5 min. Flow cytometry was
performed via a FACSCalibur ﬂow cytometer (Becton Dickinson, San
Jose, CA, USA) [19–21].2.7. Flow cytometric analysis for the plasma membrane potential
For the analysis of themembrane integrity after peptide treatment,
the log-phased cells of C. albicans (2×106/ml YPD) were harvested
and resuspended in a YPD medium, containing 18 μM of arenicin-1 or
5 μM of melittin. After incubation for 3 h, the cells were harvested by
centrifugation and suspended in PBS. Subsequently, the cells were
treated with 50 μg of bis-(1,3-dibutylbarbituric acid) trimethine
oxonol (DiBAC4(3); Molecular Probes, Eugene, OR, USA) [22]. Flow
cytometric analysis was performed via a FACSCalibur ﬂow cytometer
(Becton Dickinson, San Jose, CA, USA).
2.8. Flow cytometric analysis for morphological changes of C. albicans
protoplasts
For the preparation of C. albicans protoplasts, cells were digested
with a 10 mM phosphate buffer (pH 6.0) containing 1 M sorbitol,
lysing enzyme (Sigma) (20 mg/ml), and cellulase (Sigma) (20 mg/ml)
for 4 h at 28 °C by gentle agitation. The ﬁltrated protoplasts were
gathered by centrifugation at 1500 rpm for 10 min. The protoplasts
were resuspended in awashing buffer (1M sorbitol, 0.8 M NaCl, 10 mM
CaCl2, and 50 mM Tris–HCl, pH 7.5) and centrifuged [23,24]. The
protoplasts, resuspended in YPD medium containing 1 M sorbitol,
were treated with arenicin-1 or melittin at two times the MIC and
incubated for 2 h at 28 °C with constant shaking (80 rpm). After
incubation, the protoplast cells were harvested by centrifugation and
suspended in PBS containing 1 M sorbitol. Subsequently, the cells were
treated with PI (9 μM, ﬁnal concentration) for 5 min. Flow cytometry
was performed via a FACSCalibur ﬂow cytometer (Becton Dickinson,
San Jose, CA, USA).
2.9. Measurement of plasma membrane ﬂuorescence intensity
Fluorescence from the plasma membrane of C. albicans cells
labeled by 1,6-diphenyl-1,3,5-hexatriene (DPH) (Molecular probes,
Eugene, Oregon, U.S.A.) was used to monitor changes in membrane
dynamics. Fungal cells (2×106/ml YPD) were treated with peptides,
and incubated for 2 h at 28 °C. Samples of the fungal culturewere ﬁxed
by 0.37% formaldehyde, collected andwashedwith a PBS, and the cells
were frozen by liquid nitrogen. For labeling, cells were thawed with a
PBS buffer and resuspended in PBS. The suspension was incubated
with 0.6 mM DPH for 45 min at 28 °C, and this was followed by
washing with a PBS buffer. The ﬂuorescence intensity of DPH was
measured by a Spectroﬂuorometer (Shimadzu RF-5301PC, Shimadzu,
Japan) at 350 nm excitation and 425 nm emission wavelengths [25].
2.10. Calcein leakage measurement
Calcein-encapsulated large unilamellar vesicles (LUVs), composed
of Phosphatidylcholine (PC)/Phosphatidylethanolamine (PE)/Phos-
phatidylinositol (PI)/ergosterol (5:4:1:2, w/w/w/w), were prepared
by vortexing the dried lipid in a dye buffer solution (70 mM calcein,
10 mM Tris, 150 mM NaCl, and 0.1 mM EDTA, pH 7.4). The suspension
was freeze–thawed in liquid nitrogen for 10 cycles and extruded
Fig. 1. Time-killing kinetics of arenicin-1 against C. albicans. C. albicans (2×106 cells/ml
YPD) was incubated with arenicin-1 at 18 μM (●) or melittin at 9 μM (○). Viability was
determined every 2 h by counting colony forming units (CFUs) and expressed as
percentage of survivals. The error bars represent the standard deviation (S.D.) for three
independent experiments, performed in triplicate.
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by a LiposoFast extruder (Avestin, Inc. Canada). Untrapped calceinwas
removed by gel ﬁltration on a Sephadex G-50 column. The leakage of
calcein from the LUVs was monitored by measuring the ﬂuorescence
intensity at an excitation wavelength of 490 nm and an emission
wavelength of 520 nm on a Spectroﬂuorometer (Shimadzu RF-
5301PC, Shimadzu, Japan). The measurements were performed at
25 °C. For determination of 100% of dye release, 1% Triton X-100
(30 μl) was added to dissolve the vesicles. The percentage of dye
leakage, caused by the peptides, was calculated as follows: Dye
leakage (%)=100×(F−F0)/(Ft−F0), where F represents the leaked
ﬂuorescence intensity achieved 2 min after addition of the peptides,
and F0 and Ft represent the ﬂuorescence intensities without the
peptides and with Triton X-100, respectively [26].
2.11. Preparation of GUVs
Giant unilamellar vesicles (GUVs) were prepared by the electro-
formation method, originally developed by Angelova and Dimitrov
[27,28]. The lipid mixture solution (3.75 mg/mL) of PC/1,2-dioleoyl-
sn-glycero-3-phosphoethanolamine-N-(lissamine rhodamine B sulfo-
nyl) (ammonium salt) (18:1 Liss Rhod PE)/PI/ergosterol (5:4:1:2, w/
w/w/w) dissolved in chloroform was spread onto a ITO (indium tin
oxide) coated glass. The lipid-coated ITO glass was evaporated under a
vacuum for 2 h. Both lipid-coated and uncoated glasses were held at a
distance of 2mmby a thin Teﬂon spacer. After ﬁlling the chamberwith
10mM HEPES buffer solution (pH 7.4), a sinusoidal 1.7 Vpp (peak-to-Fig. 2. The effect of arenicin-1 on the dimorphic transition in C. albicans. Each culture was in
without FBS and arenicin-1, (B) Cells treated with only 20% FBS, (C) Cells treated with 20%peak) and 10 Hz frequency was applied for 2 h at room temperature.
To detach the vesicles from the plate, a sinusoidal 4 Vpp and 4 Hz
frequency was applied for 10 min. Ten microliters of GUV aliquots
solution were observed on an inverted ﬂuorescence phase-contrast
microscope (Leica DFC 420C). Peptide solutions were added after the
selection of a single GUV.
3. Results and discussion
3.1. Antifungal activity of arenicin-1
Arenicin-1 (RWCVYAYVRVRGVLVRYRRCW) is a 21-residue anti-
bacterial peptide which was isolated from the coelomocytes of the
marine polychaeta lugworm, Arenicola marina [8,9]. It has been
reported to show potent antibacterial activity against bacterial strains
[10], while its antifungal effects and mechanisms are poorly under-
stood. To determine whether arenicin-1 possessed antifungal activity,
we investigated the effects of the arenicin-1 towards various human
pathogenic fungal strains. In this study, melittin (GIGAVLKVLTTGLPA-
LISWIKRKRQQ-NH2), a 26 residue peptide which is the principal toxic
component in the venom of the European honey bee Apis mellifera,
was used as a reference for comparison with arenicin-1. Its lytic
activity is intrinsic and powerful enough to exhibit potent hemolytic
and antimicrobial activity [29].
The antifungal activity of arenicin-1 was determined by MTT assay
[14]. The result showed that all fungal strains tested were highly
susceptible to arenicin-1 with MIC values in 4.5–9 μM range (Table 1).
Signiﬁcantly, arenicin-1 exerted strong inhibitory effects towards the
Candida species including C. albicans. C. albicans is the most prevalent
systemic fungal pathogen of man and is associated with a range of
clinical conditions ranging from irritating superﬁcial infections of the
oral and vaginal mucosa to life-threatening systemic disease in
immunocompromised patients [30]. Considering these medical
importance, C. albicans has been selected as a model organism in
the following experiments.
In time-killing kinetics, the CFUs of the C. albicans cells rapidly
decreased after treatment with arenicin-1 and the complete killing of
C. albicans was observed after 6 h. As showing similar trend with
respect to melittin, the killing of fungal cells by arenicin-1 was
considerably fast (Fig. 1). These observations suggest that arenicin-1
possesses a signiﬁcant fungicidal effect and rapid killing mechanism
against C. albicans. Although the fungicidal effect of arenicin-1 was
less potent than that of melittin, these results indicate that arenicin-1
has such a remarkable level of fungicidal effect as to have the potential
to be considered as a candidate for drug therapy or as a template for
drug design.
To further conﬁrm the fungicidal activity of arenicin-1, the effect of
arenicin-1 on the dimorphic transition in C. albicanswas investigated.
With respect to C. albicans, the dimorphism plays a crucial role in the
pathogenesis, with mycelial shapes being predominantly found
during a host tissue invasion [31]. As shown in Fig 2, the serum-cubated for 48 h in YPD medium with 20% fetal bovine serum (FBS). (A) Yeast control
FBS and 9 μM of arenicin-1.
Fig. 3. The effects of NaN3 on antifungal activity of arenicin-1. C. albicans (2×106 cells/
ml YPD) was incubated with 0.1 mM NaN3 for 1 h. After incubation, the cells treated
with arenicin-1 at 18 μM. The cell population showed by MTT assay. The absorbance of
each well was measured at 580 nm by using a Microtiter ELISA Reader (Molecular
Devices Emax). The equation of cell viability percentage: [(the absorbance of the
compound-treated cells)/(the absorbance of non-treated cells)]×100. The error bars
represent the standard deviation (SD) values for three independent experiments,
performed in triplicate.
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destroyed in the presence of arenicin-1 (Fig. 2C), while the mycelia in
the absence of arenicin-1 formed normally (Fig. 2B).
3.2. Effect of energy metabolism on antifungal activity of arenicin-1
It was further investigated as to whether the energy charge of C.
albicans cells inﬂuences their susceptibility to arenicin-1. For this
purpose, cells were incubated with arenicin-1 in the presence of
0.1 mM sodium azide, which inhibits metabolic ATP synthesis in
mitochondria [32]. ATP depletion causes various changes in cellFig. 4. Flow cytometric analysis of membrane permeablization assay and salt-sensitivity tes
YPD) was incubatedwith arenicin-1 ormelittin for 2 h at 28 °C. (a) Control, (b) 18 μMarenicin
arenicin-1. The distributions of cells according to relative ﬂuorescence intensities are given.
melittin at 5 μM. The depolarization of the cell membrane was detected by the incubation
stained DiBAC4(3) after C. albicans were treated with peptides.membranes by the regulation of intracellular pH [33]. As illustrated in
Fig. 3, in the presence of the metabolic inhibitor which blocks both the
conventional as well as the alternative respiratory pathways of C.
albicans cells, a decrease of the antifungal activity was observed. This
result suggests that the change of cellular physiological conditions,
which poses a membrane rigidiﬁcation by energy depletion [34],
desensitizes C. albicans to arenicin-1. Conversely, this point lead us to
speculation that the antifungal action site of arenicin-1 could be
fungal plasma membrane, provided that membrane rigidiﬁcation by
energy depletion blocks the membrane-active effect, that is, insertion
into and disruption or pore/ion channel formation in cytoplasmic
membrane, of arenicin-1.
3.3. Interaction of arenicin-1 with fungal membranes
Naturally occurring antimicrobial peptides are the ﬁrst step of self-
defense against invading pathogenic microorganisms. Antimicrobial
peptides take charge of the ﬁrst-line defense system and possess
several features adequate to their function. For rapid killing, the site of
action should preferably be the cell surface rather than the cell interior.
Also, the development of resistance is considered to be difﬁcult if the
target molecules are important components conserved among micro-
organisms. To fulﬁll these requirements, many of the self-defense
peptides act on the cytoplasmic membranes of microorganisms [35].
Therefore, initially, the effect of arenicin-1 on the membrane integrity
was investigated by monitoring the inﬂux of PI, a DNA-staining
ﬂuorescent probe, into C. albicans cells [36] (Fig. 4A). PI, a membrane-
impermeant dye, only enters membrane compromised cells, after
which the ﬂuorescence of this probe is enhanced by 20–30-fold due to
its binding to nucleic acids [37]. The treatment of C. albicans with
arenicin-1 at two times the MIC caused an inﬂux of PI into the fungal
cells. This result indicates that arenicin-1 affects fungal cells by injuring
their membranes, and thus increasing its permeability.
Based on models regarding the mode of actions of antimicrobial
peptides [38,39], their initial interactions with microbial membranest by PI uptake and of DiBAC4(3) staining in C. albicans. (A) C. albicans (2×106 cells/ml
-1, (c) 5 μMmelittin, (d) 150mMNaCl and 18 μMarenicin-1, (e) 3mMMgCl2 and 18 μM
(B) C. albicans (2×106 cells/ml YPD) was incubated for 3 h with arenicin-1 at 18 μM or
of peptide-treated cells in DiBAC4(3). Histograms showed the ﬂuorescence intensity of
Fig. 5. Three-dimensional ﬂow cytometric contour-plot analysis of C. albicans protoplasts treated with arenicin-1 at 18 μMormelittin at 5 μM. FS (y-axis) is an indicator of size and SS
(90° scattering, SS LOG, x-axis) is an indicator of granularity. The z-axis represents the cellular population intensity.
1794 C. Park, D.G. Lee / Biochimica et Biophysica Acta 1788 (2009) 1790–1796are believed to be electrostatic. Thus, an increasing ionic strength
under high salt conditions will likely weaken the electrostatic
interactions between antimicrobial peptides and microbial mem-
brane, thereby reducing the antimicrobial activity [40]. However, the
result showed that the antifungal activity of arenicin-1 against C.
albicanswas still retained at physiological salt concentration and even
at higher concentration (150 mM NaCl, 3 mM MgCl2) (Fig. 4A). This
result suggests that electrostatic interaction does not have a role in
maintaining antifungal activity of arenicin-1. As Tam et al. indicated,
the structural characteristics of arenicin-1 containing amonocluster of
cationic residues possibly contribute to the retention of membrane-
active antifungal activity under high salt condition [41].
To further assess as to whether arenicin-1 can affect the functions
of the fungal plasma membrane, its ability to dissipate the membrane
potential of C. albicanswas investigated. In the presence or absence of
peptides, the amounts of accumulated DiBAC4(3) in C. albicans cells
were analysed with ﬂow cytometry. DiBAC4(3) has a high voltage
sensitivity and only can enter depolarized cells, in which it binds to
lipid-rich intracellular components [22]. Cells treated with arenicin-1
caused the accumulation of DiBAC4(3) with respect to peptide-
untreated cells (Fig. 4B), suggesting that arenicin-1 damages the
membrane and induces the membrane depolarization of fungal cells.
The morphological effects of arenicin-1 on C. albicans were
investigated by ﬂow cytometric analysis plotting the forward scatter
and side scatter of treated and untreated cells. In particular, the
protoplasts of C. albicans were utilized to conﬁrm the effect of
arenicin-1 at the level of fungal cytoplasmic membrane. As shown in
Fig. 5, in the absence of peptides, a homogeneous population of
undamaged cells was observed. In the presence of arenicin-1 at twoFig. 6. DPH ﬂuorescence analysis after addition of various concentrations of arenicin-1
(●) or melittin (○). The error bars represent the standard deviation (SD) values for
three independent experiments, performed in triplicate.times the MIC, a population of damaged and permeabilized cells
became dominant. The results showed that arenicin-1 and melittin
permeabilized fungal membrane, leading to a similar necrotic effect,
characterized by increased an PI uptake and decreased FS in regards to
ﬂow cytometric experiments [42].
The fundamental architecture of biomembranes is the lipid bilayer.
Its self-sealing property as well as its ﬂuidity creates an ideal structure
for the cellular membrane [43]. To elucidate membrane ﬂuidity by
arenicin-1, changes in membrane dynamics were examined with a
ﬂuorescent membrane probe, DPH. DPH is a hydrophobic molecule,
and this characteristic enables it possible to associate with the
hydrocarbon tail region of phospholipids, within the cytoplasmic
membrane, without disturbing the structure of the lipid bilayer
[44,45]. If the antifungal activity exerted by arenicin-1 on C. albicans is
at the level of the lipid bilayer, then the DPH, which interacts with an
acyl group of the lipid bilayer within the plasmamembrane, could not
be inserted into the membrane. The results showed that increasing
peptide concentrations signiﬁcantly decreased the plasma membrane
DPH ﬂuorescence intensity (Fig. 6). This DPH ﬂuorescence intensity
reﬂects the fungicidal effect of arenicin-1 against C. albicans cells, by
perturbing the plasma membrane. This also suggests that the fungal
plasma membrane is structurally perturbed when exposed to
arenicin-1.
An artiﬁcial lipid bilayer was utilized to further characterize the
capacity of arenicin-1 to disrupt the fungal plasma membrane. To
determine whether arenicin-1 could cause the leakage of calcein fromFig. 7. Percent leakage of ﬂuorescent dye from calcein-entrapped LUVs, composed of
PC/PE/PI/ergosterol (5:4:1:2, w/w/w/w), in the presence of arenicin-1 (●) or melittin
(○). The percentage of dye leakage caused by the peptides was calculated as follows:
Dye leakage (%)=100×(F−F0)/(Ft−F0), where F is the leaked ﬂuorescence intensity
achieved 2 min after addition of the peptides, and F0 and Ft are the ﬂuorescence
intensities without the peptides and with Triton X-100, respectively.
Fig. 8. The response of the single GUV composed of PC/PE/PI/ergosterol (5:4:1:2, w/w/w/w) to the treatment with peptides. For arenicin-1, (A–C) were obtained at 0, 3, and 5 min.
respectively. For melittin, (D–F) were obtained at 0, 0.1, and 1 min, respectively. The scale bar represents 10 μm.
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unilamellar vesicles (LUVs) having a phospholipid composition
resembling the bilayer of C. albicans composed of 5:4:1:2 (w/w/w/w)
PC/PE/PI/ergosterol [46] was conducted. Melittin caused a complete
leakage of calcein from the vesicles at 9 μM, whereas 18 μM of arenicin-
1 induced a 60% leakage of calcein from LUVs (Fig. 7). The leakage
potency of arenicin-1 supports that the lipid bilayer within the plasma
membrane is the presumptive fungicidal action site for arenicin-1.
The observation of the morphological changes of a single giant
unilamellar vesicle (GUV) responding to peptides offered additional
information about the membrane-active mechanism of arenicin-1.
Due to their size, the GUVs are a suitable model with respect to cell
membranes and, furthermore, permit direct observations of the
vesicle–peptide interaction [47–49]. A single yeast size-like GUV
which resembles the phospholipid bilayer of C. albicans composed of
5:4:1:2 (w/w/w/w) PC/PE/PI/ergosterol [46] was selected and then
treated with peptides. The shape of a selected single vesicle was
monitored continuously by phase-contrast microscopy. The observed
response of each single vesicle to peptides was different (Fig. 8).When
treated with melittin, one side of a GUV was rapidly protruded and
burst to cause complete lysis and disintegration of membrane, thereby
leaving a small lump of lipid membrane (Fig. 8D–F). The lag phase
(10 s) was remarkably short and a complete response was concluded
within 1 min. On the other hand, a single GUV treated with arenicin-1
slightly crumpled and diminished in size (Fig. 8A–C). After an initial
lag phase of 2 min, the single GUV began to shrink and the whole
response of it gradually processed for 5 min from start to ﬁnish. The
lag phase probably indicates that arenicin-1 accumulates on the
membrane until a critical concentration is reached, after which the
peptides may cooperatively induce membrane destruction [50]. These
observations demonstrate that the major target site of arenicin-1 is
the fungal membrane and it is thought that arenicin-1 contains
membrane-active mechanism(s).
In summary, the fungicidal effect and its mode of action of
arenicin-1 were investigated. Although the exact mechanisms(s) at
themolecular level are not completely understood, this study suggests
that arenicin-1 is likely to exert fungicidal effect by disturbing fungal
membrane. Therefore, it can be concluded that understandingfungicidal effect and these modes of action of arenicin-1 may help
in the design of more potent as well as more speciﬁc antimicrobial
peptides.
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